preview

Are the Drugs Worth the Risk?

Best Essays
In 1993, Ron and Iris had a baby boy named Jacob and until the age 3, Jacob did not show any signs of a mental disorder. Due to what the teacher referred to as problematic behavior, Jacob was kicked out of mommy and me and at the age of 4, Jacob’s pre-school teacher suggested that he be put on medication for Attention Deficit Hyperactivity Disorder, commonly referred to as ADHD, for his lack of impulse control. After several more teachers suggested the same thing, Ron and Iris stopped resisting and took Jacob to a psychiatrist. The psychiatrist put the child that was now 5 years old, on Ritalin, the most common medication used to treat ADHD. Ritalin caused Jacob to feel anxious, so his psychiatrist prescribed a second drug to treat the anxiety. But shortly after starting the second medication Jacob began to develop the symptoms of OCD, or Obsessive Compulsive Disorder, which caused him to be placed on a third medication. This cycle of each drug Jacob was given resulting in another drug to treat the side effects continued until the child was taking 8 different medications a day. His parents, who had now fed their child mind- altering drugs for 4 years were still uneasy about if the drugs were helping their son, but continued to give the medications because they did not know there were alternatives. At 9, Jacob received the diagnosis of a mood disorder and began a new cycle of medications. In 2003, after Jacob had been placed onto such a large variety of medication, his parents wanted to stop his treatment plan, so they hospitalized their 10 year old in order for him to be stripped off all the medications. Within the first 24 hours of being stripped off the medications, Jacob was diagnosed, this time with Bipolar Disorder, a di... ... middle of paper ... ...b;9(1):59-73(2001): www.ncbi.nlm.nih.gov/pubmed/11519636. Stubbe, D. (2007). Disruptive Behavior Disorder. In C. Mitchell (Ed.), Child and Adolescent Psychiatry (pp. 57-69). Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins. U.S. Food and Drug Administration. (2012, January 30). Pediactric Focused Safety Review. Retrieved March 1, 2012, from fda.gov: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM289943.pdf U.S. Food and Drug Administration. (2012, January). Vyvanse drug facts. Retrieved March 1, 2012, from sharecontent.com: http://pi.shirecontent.com/PI/PDFs/Vyvanse_USA_ENG.pdf York University. (2008, January). Big Pharma Spends More On Advertising Than Research And Development. Retrieved March 1, 2012, from Science Daily: http://www.sciencedaily.com/releases/2008/01/080105140107.htm
Get Access